Frontiers | How Does Thymus Infection by Coxsackievirus Contribute to the Pathogenesis of Type 1 Diabetes?
Alternatively Spliced Soluble Coxsackie-adenovirus Receptors Inhibit Coxsackievirus Infection* - Journal of Biological Chemistry
Prenylated C6–C3 derivatives from the stems and branches of Illicium ternstroemioides A. C. Smith with antiviral activity - ScienceDirect
Coxsackievirus B3 replication and pathogenesis | Future Microbiology
MicroRNA Modification of Coxsackievirus B3 Decreases Its Toxicity, while Retaining Oncolytic Potency against Lung Cancer: Molecular Therapy - Oncolytics
Molecular basis of Coxsackievirus A10 entry using the two-in-one attachment and uncoating receptor KRM1 | PNAS
Antiviral Activity of Oroxylin A against Coxsackievirus B3 Alleviates Virus-Induced Acute Pancreatic Damage in Mice | PLOS ONE
PDF) Hand-foot-and-mouth disease virus receptor KREMEN1 binds the canyon of Coxsackie Virus A10
Coxsackie Virus RT-PCR
Extremely Low Organ Toxicity and Strong Antitumor Activity of miR-34-Regulated Oncolytic Coxsackievirus B3 - ScienceDirect
Frontiers | Neonatal Murine Model of Coxsackievirus A2 Infection for the Evaluation of Antiviral Therapeutics and Vaccination
Download PDF | Coxsackie A16 Virus-associated Atypical Hand-foot-and-mouth Disease
Dr. Daniel | Functional Medicine
Cum se manifestă infecţia cu virusurile Coxsackie
Microorganisms | Free Full-Text | Innate Viral Sensor MDA5 and Coxsackievirus Interplay in Type 1 Diabetes Development | HTML
Persistent coxsackievirus B1 infection triggers extensive changes in the transcriptome of human pancreatic ductal cells - ScienceDirect
Coxsackievirus Type B3 Is a Potent Oncolytic Virus against KRAS-Mutant Lung Adenocarcinoma: Molecular Therapy - Oncolytics
Cryo-EM structures reveal the molecular basis of receptor-initiated coxsackievirus uncoating - ScienceDirect
A hexavalent Coxsackievirus B vaccine is highly immunogenic and has a strong protective capacity in mice and nonhuman primates | Science Advances
Coxsackie B4 virus infection of β cells and natural killer cell insulitis in recent-onset type 1 diabetic patients | PNAS
A Short History and Introductory Background on the Coxsackieviruses of Group B | SpringerLink
AC. ANTI COXSACKIE A VIRUS (A2,4,7,9,10,16) – laboratorios
Experimental autoimmune myocarditis versus coxsackievirus B3 induced... | Download Scientific Diagram
